Skip to main content
Delfa

Lead sponsor

Chang Gung Memorial Hospital

7 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.

7

Trials led

2

Ongoing

637

Total enrollment

5

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 2
7

Trials by status

Recruiting
2
Completed
4
Suspended
1

Trials led

TrialEligibility highlightPhaseStatusEnrollment
The Dose Finding Study of DAOIB Added to tDCS for ADAlzheimer's diseasePh 2Suspended140
Efficacy Biomarkers of DAOIB for DementiaAlzheimer's diseasePh 2Recruiting123
DAOIB Combined With tDCS for Early-phase DementiaAlzheimer's diseasePh 2Completed97
DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of DementiaMultiple dementia etiologiesPh 2Completed90
NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's DiseaseAlzheimer's diseasePh 2Completed86
Novel Augmentation of DAOIB and Antioxidant for Early DementiaAlzheimer's diseasePh 2Recruiting80
To Evaluate the Efficacy and Safety/Tolerability Profiles of G-CSF in Subjects With Mild to Moderate Alzheimer's DiseaseMMSE 12-26Ph 2Completed21